Sign in
8-K

Current Report

Avalo Therapeutics, Inc. Filed Acc 0001558370-16-008293

Material agreement · Delisting notice · Executive or director change · Other events

  • Item 1.01 Entry into a material definitive agreement
  • Item 3.01 Notice of delisting or failure to meet a listing standard
  • Item 5.02 Departure or appointment of directors or officers
  • Item 8.01 Other events

From the SEC's structured data for this filing

Loading cerc-20160912x8k.htm…